GC19099
CeMMEC13
Also known as N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methyl-2-oxoquinoline-4-carboxamide
CeMMEC13 is a potent inhibitor of TAF1 (2) bromodomain, with an IC50 of 2·1 uM
ChemicalCAS1790895-25-8MW336.34FormulaC19H16N2O4
- CAS number
- 1790895-25-8
- Molecular weight
- 336.34
- Formula
- C19H16N2O4
- Solubility
- DMSO ： ≥ 30 mg/mL (89·20 mM)
- InChIKey
- NXKBPGZQDHACPZ-UHFFFAOYSA-N
- Catalogue number
- GC19099
- Brand
- GLPBIO
Computed properties PubChem CID 110694558 · XLogP 1.8 · TPSA 67.9 Ų · H-bond donors 1
- XLogP
- 1.8
- TPSA
- 67.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 25
SMILES CN1C2=CC=CC=C2C(=CC1=O)C(=O)NC3=CC4=C(C=C3)OCCO4
Computed descriptors from PubChem (CID 110694558), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il